Macrogenics (MGNX) Invested Capital (2016 - 2025)
Historic Invested Capital for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to $67.0 million.
- Macrogenics' Invested Capital fell 4419.65% to $67.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.0 million, marking a year-over-year decrease of 4419.65%. This contributed to the annual value of $116.1 million for FY2024, which is 2395.34% down from last year.
- Per Macrogenics' latest filing, its Invested Capital stood at $67.0 million for Q3 2025, which was down 4419.65% from $46.6 million recorded in Q2 2025.
- In the past 5 years, Macrogenics' Invested Capital registered a high of $350.5 million during Q1 2021, and its lowest value of $46.6 million during Q2 2025.
- Its 5-year average for Invested Capital is $158.2 million, with a median of $142.0 million in 2022.
- In the last 5 years, Macrogenics' Invested Capital skyrocketed by 8393.53% in 2021 and then crashed by 6629.49% in 2024.
- Macrogenics' Invested Capital (Quarter) stood at $239.6 million in 2021, then plummeted by 40.73% to $142.0 million in 2022, then rose by 7.46% to $152.6 million in 2023, then decreased by 23.95% to $116.1 million in 2024, then crashed by 42.27% to $67.0 million in 2025.
- Its Invested Capital stands at $67.0 million for Q3 2025, versus $46.6 million for Q2 2025 and $79.1 million for Q1 2025.